Literature DB >> 30994416

Better therapeutic potential of bone marrow-derived mesenchymal stem cells compared with chorionic villi-derived mesenchymal stem cells in airway injury model.

Shimeng Ji1, Chaomin Wu2, Lin Tong1, Linlin Wang1, Jian Zhou1, Cuicui Chen1, Yuanlin Song1,2,3,4.   

Abstract

Aim: To determine the efficiency of mesenchymal stem cells (MSCs) of different sources on airway epithelial cells regeneration and track where and to what extent transplanted MSCs home to injured tissues. Materials & methods: We performed DiO-labeled human bone marrow-derived MSCs (hBMSCs) or human chorionic villi-derived MSCs transplantation studies using naphthalene-induced airway injury animal models.
Results: Compared with human chorionic villi-derived MSCs, hBMSCs facilitated airway epithelium regeneration faster and better from day 5 after transplantation; moreover, more transplanted hBMSCs distributed in injured lung tissues at the early stage of postinjury, which was mediated by C-X-C motif chemokine ligand 12.
Conclusion: hBMSCs possessed better potential of migration to the damaged lung and promoting the repair of the injured airway epithelium.

Entities:  

Keywords:  ; airway injury; bronchiolar epithelial cell; mesenchymal stem cell; naphthalene; regeneration

Year:  2019        PMID: 30994416     DOI: 10.2217/rme-2018-0152

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  3 in total

1.  Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/β-catenin.

Authors:  Xiaotong Yang; Xiaoying Ma; Ocholi Don; Yuanlin Song; Xiaoyan Chen; Jianwen Liu; Jieming Qu; Yun Feng
Journal:  Stem Cell Res Ther       Date:  2020-05-19       Impact factor: 6.832

2.  Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/β-catenin signaling pathway.

Authors:  Yun Feng; Linlin Wang; Xiaoying Ma; Xiaotong Yang; Ocholi Don; Xiaoyan Chen; Jieming Qu; Yuanlin Song
Journal:  Stem Cell Res Ther       Date:  2020-01-03       Impact factor: 6.832

Review 3.  Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.

Authors:  Pooja Yadav; Ravina Vats; Afsareen Bano; Rashmi Bhardwaj
Journal:  Life Sci       Date:  2020-10-10       Impact factor: 5.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.